IV 

111TH CONGRESS 

1ST SESSION H. RES. 35 

Expressing the sense of the House of Representatives that Congress should 

provide increased Federal funding for continued type 1 diabetes research. 

IN THE HOUSE OF REPRESENTATIVES 

JANUARY 8, 2009 

Mr. GENE GREEN of Texas submitted the following resolution; which was 

referred to the Committee on Energy and Commerce 

RESOLUTION 

Expressing the sense of the House of Representatives that 

Congress should provide increased Federal funding for 

continued type 1 diabetes research. 

Whereas as many as 3,000,000 Americans suffer from type 

1 diabetes, a chronic, genetically determined, debilitating 

disease affecting every organ system; 

Whereas more than 15,000 children each year are diagnosed 

with type 1 diabetes, a disease caused by an autoimmune 

attack that destroys the insulin-producing beta cells of 

the pancreas; 

Whereas diabetes is one of the most costly chronic diseases, 

costing the United States economy more than 

$174,000,000,000 and costing individuals with diabetes 

an average of $13,000 in annual health care costs, compared to $2,600 for individuals without diabetes; 


wwoods2 on PRODPC68 with BILLS
2 

•HRES 35 IH 

Whereas insulin treats but does not cure this potentially 

deadly disease and does not prevent the complications of 

diabetes, which include blindness, heart attack, kidney 

failure, stroke, nerve damage, and amputations; 

Whereas the National Institutes of Health has established 6 

goal areas to guide type 1 diabetes research focused on 

the reduction, prevention, and cure of type 1 diabetes 

and its complications; 

Whereas Federal funding has enabled research focused on determining the underlying genetic and environmental 

causes of diabetes and testing of promising new treatments to halt and reverse the autoimmune attack causing 

type 1 diabetes; 

Whereas a cure for type 1 diabetes will require restoring beta 

cell function either by replacement with transplantation 

or by beta cell regeneration; 

Whereas the development of a ‘‘closed-loop’’ artificial pancreas would greatly alleviate the daily burden of disease 

management for type 1 diabetes patients by continuously 

monitoring blood sugar levels, infusing insulin as necessary when blood glucose levels become too high, and 

warning patients when blood glucose levels become dangerously low; 

Whereas continued progress toward a cure for type 1 diabetes 

depends on training the next generation of diabetes researchers; 

Whereas a strong public-private partnership to fund type 1 

diabetes exists between the Federal Government and the 

Juvenile Diabetes Research Foundation International, a 

foundation which has awarded more than $1,000,000,000 

for diabetes research since its founding and in fiscal year 


wwoods2 on PRODPC68 with BILLS
3 

•HRES 35 IH 

2008 provided more than $156,000,000 for diabetes research in 20 countries; 

Whereas Congress has provided $150,000,000 annually 

through fiscal year 2011 for the Special Statutory Funding Program for type 1 Diabetes Research; 

Whereas the National Institutes of Health devoted a total of 

$433,000,000 in fiscal year 2009 for type 1 diabetes research; and 

Whereas leading type 1 diabetes researchers have recommended a total funding level of $4,100,000,000 for 

fiscal years 2009 through 2013 in order to meet the National Institutes of Health’s type 1 research goals: Now, 

therefore, be it 

1 Resolved, That Federal funding for diabetes research 

2 should be increased to meet the National Institutes of 

3 Health’s goals so that a cure for type 1 diabetes can be 

4 found. 

Æ 


wwoods2 on PRODPC68 with BILLS